attachment
attachment

Answer all these questions

analyse_media
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
I now have comprehensive material to answer all four questions. Let me compile the complete answers.

CHOLERA - Past Questions: Complete Answers


Question 1 (3+4=7 marks, 2073)

"We often read and review the history how cholera was controlled in mid nineteenth century in the resource rich countries... How do you see this problem in Nepal and what public health approach did the resource rich countries adopt... and also describe the stakeholder responsible with robust solution to bring down the cases to minimum in context to Nepal."

Part A (3 marks): How cholera was controlled in resource-rich countries

In the mid-19th century, cholera was controlled in now-rich countries primarily through large-scale infrastructural development and public health legislation - long before the germ theory was fully understood:
  1. Safe water supply - Construction of piped, treated water systems with chlorination. John Snow's 1854 Broad Street pump investigation in London demonstrated the waterborne route and led to removal of contaminated pump handles - a landmark event.
  2. Sanitary sewage disposal - Major sewer construction separated drinking water from fecal waste (e.g., London's Great Stink of 1858 triggered building of the Thames Embankment sewers by Joseph Bazalgette).
  3. Improved nutrition and living conditions - Overcrowding reduced in cities, slum clearance programs began.
  4. Notification and surveillance systems - Legal frameworks made cholera a notifiable disease, enabling rapid outbreak response.
  5. Food safety regulation - Laws governing food preparation and market hygiene.
These "WASH" (Water, Sanitation, and Hygiene) interventions brought the disease under control before any vaccine existed, and remain the gold standard today (Harrison's Principles, 22E).

Part B (4 marks): Epidemiological situation in Nepal and responsible stakeholders with solutions

Cholera in Nepal:
Nepal experiences repeated cholera outbreaks particularly during the monsoon season (June-September). The disease disproportionately affects peri-urban slums of Kathmandu, hilly remote districts with poor access, and areas affected by floods and displacement. Despite multiple national efforts:
  • Open defecation remains prevalent in rural areas.
  • Only ~73% of the population has access to basic water supply, and water quality is often compromised.
  • Post-earthquake (2015) and flood-related outbreaks have been recurrent.
  • Poor surveillance infrastructure leads to under-reporting.
  • The 7th pandemic El Tor biotype (V. cholerae O1) is dominant.
Key Stakeholders and Their Roles:
StakeholderResponsibility
Ministry of Health and Population (MoHP)Surveillance, notification to WHO, Integrated Disease Surveillance (IDSP), national treatment protocols
Ministry of Water SupplySafe drinking water supply, especially in endemic areas
Ministry of Federal Affairs & Local Governments (Municipalities/Wards)Sanitation, solid waste management, latrine construction
WHO Nepal / UNICEFTechnical support, ORS supplies, outbreak response coordination
ICIMOD / UNDPClimate-risk linked cholera early warning systems
Community Health Workers (FCHVs/ANMs)Grassroots case detection, health education, ORS distribution
Academic institutions (IoM, BPKIHS)Capacity building, research, surveillance
INGOs/NGOs (Oxfam, IRC)Emergency WASH response, especially in disaster contexts
Robust Solutions for Nepal:
  1. Accelerate universal WASH coverage - prioritize piped treated water and sanitation in all municipalities.
  2. Integrate cholera vaccine (oral killed vaccine - Shanchol/Euvichol) into outbreak response and high-risk area preventive campaigns, as per WHO GTFCC 2030 strategy.
  3. Strengthen disease surveillance - real-time reporting from health posts to central level.
  4. Disaster-preparedness plans with pre-positioned ORS and IV fluids in flood-prone districts.
  5. Inter-ministerial coordination (One WASH National Program) to synchronize health, water, and local government efforts.

Question 2 (10 marks, 2068)

"Discuss why cholera remains a public health problem in Nepal and in other developing countries despite several national efforts to prevent it."

Why Cholera Persists - A Multi-level Analysis

Cholera remains a "key indicator of lack of social development" (Park's Textbook of PSM). Despite national programs, the disease persists due to complex, interconnected factors:

1. Agent Factors

  • V. cholerae O1 (El Tor biotype) and O139 have a high environmental persistence - they survive in surface water, coastal estuaries, and freshwater with adequate warmth and nutrients.
  • El Tor has a higher infection-to-case ratio (many asymptomatic carriers silently spread the organism).
  • Emergence of new El Tor variant strains with higher virulence and antimicrobial resistance.
  • The infectious dose is low in hypochlorhydric individuals (malnourished, elderly, antacid users) - a common scenario in low-income populations.

2. Host Factors

  • Malnutrition reduces gastric acid, lowering the infective dose threshold.
  • Immunosuppression (HIV, malnutrition) increases susceptibility.
  • Low pre-existing immunity - communities newly exposed lack herd protection.
  • Illiteracy and low health literacy reduce adoption of hand hygiene and ORS use.
  • Blood group O individuals are at higher risk for severe cholera.

3. Environmental / Social Determinants

  • Unsafe water supply: Nepal's piped water is intermittent and frequently contaminated. Open wells and rivers serve as primary water sources in many rural areas.
  • Inadequate sanitation: Open defecation in rivers/streams that serve as drinking water sources - classic fecal-oral transmission.
  • Overcrowded urban slums (Kathmandu valley): Dense housing, poor drainage.
  • Seasonal flooding: Monsoon floods (June-September) contaminate water supplies annually. Climate change is worsening flood frequency.
  • Disaster vulnerability: Earthquakes, landslides, and floods disrupt water/sanitation infrastructure.
  • Population displacement: Migrants moving from endemic rural areas to urban centers.

4. Health System Weaknesses

  • Weak disease surveillance: Many cases are unreported, especially at community level; cholera is still stigmatized (fear of trade/travel restrictions).
  • Inadequate peripheral health infrastructure: Shortage of IV fluids, ORS stocks, and trained health workers in remote areas.
  • Delayed case detection: Without active surveillance, outbreaks are identified late, when transmission has already expanded.
  • Limited use of cholera vaccines: Oral killed vaccines are underutilized in Nepal for pre-outbreak prophylaxis.
  • Funding gaps: Sanitation and water supply programs are chronically underfunded.

5. Programmatic / Policy Failures

  • Lack of intersectoral coordination between health, water supply, and local governments.
  • Programs focus on curative response rather than sustained preventive infrastructure.
  • Community engagement is superficial - behavior change communication is limited.
In summary, cholera persists because it is fundamentally a disease of poverty, inadequate infrastructure, and weak governance - factors that cannot be addressed by health-sector interventions alone. The "introduction of cholera into any country cannot be prevented, but cholera can create a problem only in areas where sanitation is defective" (Park's PSM).

Question 3 (8 marks, 2064)

"Describe the epidemiological situation of cholera and its determinants in Nepal. Illustrate the principles of case management, prevention and control of cholera."

A. Epidemiological Situation in Nepal

  • Cholera is both endemic and epidemic in Nepal.
  • Outbreaks occur primarily during monsoon (June-September), linked to flooding and water contamination.
  • Cases cluster in: Kathmandu valley, Terai plains (flood-prone), and remote hilly districts with poor WASH.
  • The causative strain is predominantly V. cholerae O1 El Tor biotype, serotypes Ogawa and Inaba.
  • True burden is underestimated due to poor surveillance; most cases are mild/asymptomatic.
  • Post-earthquake 2015 saw a significant spike in diarrheal disease cases.
  • Global warming is creating increasingly favorable conditions for V. cholerae proliferation.

B. Epidemiological Determinants

Agent factors:
  • V. cholerae O1 (El Tor) and O139; El Tor has greater endemic tendency.
  • Produces cholera toxin (CT) - an enterotoxin that activates adenylate cyclase, raises cyclic AMP, causing massive secretion of isotonic fluid into the gut.
  • Incubation period: a few hours to 5 days (usually 1-3 days).
  • Reservoir: humans and aquatic environment (plankton-associated).
Host factors:
  • All ages susceptible; in endemic areas it is predominantly a pediatric disease.
  • Pre-existing immunity (from mild/subclinical infection) is protective but temporary.
  • Gastric achlorhydria, blood group O, and malnutrition increase severity.
  • Incubation period: 6 hours to 5 days.
Environmental factors:
  • Contaminated water (most common vehicle) and food (raw/undercooked seafood, street food).
  • Poor sanitation and open defecation.
  • Overcrowding, flooding, monsoon season.
  • No animal reservoir.

C. Case Management (Principles)

The cornerstone of cholera management is rapid rehydration - mortality has been reduced to <1% with effective rehydration therapy (Park's PSM).
Step 1 - Assess dehydration severity:
  • Mild (<5% body weight loss): ORS at home
  • Moderate (5-10%): ORS at treatment center, monitor
  • Severe (>10%): IV rehydration urgently (Ringer's lactate preferred)
Step 2 - Oral Rehydration Therapy (ORT):
  • WHO standard ORS: NaCl 3.5g, KCl 1.5g, NaHCO3 2.5g, Glucose 20g per liter of clean water.
  • Give 75 ml/kg over 4 hours for moderate dehydration; reassess.
  • Reduced-osmolarity ORS is currently preferred.
Step 3 - IV Rehydration:
  • Ringer's lactate: 100 ml/kg over 3 hours (adults) / 3.5 hours (children).
  • Normal saline if Ringer's lactate unavailable.
  • Monitor pulse, BP, urine output, skin turgor.
Step 4 - Antibiotic therapy (adjunct):
  • Start antibiotics after vomiting stops (usually 3-4 hours after ORT begins).
  • Azithromycin (preferred, especially for children and pregnant women)
  • Doxycycline/Tetracycline (adults - single dose effective)
  • Ciprofloxacin/Fluoroquinolones (where sensitive)
  • TMP-SMX (alternative)
  • Avoid antidiarrhoeals, antiemetics, corticosteroids - they are contraindicated.
  • If diarrhea persists >48 hours despite antibiotics, suspect antimicrobial resistance.
Step 5 - Feeding:
  • Resume feeding as soon as possible; breastfeeding must be continued in infants.
  • Zinc supplementation in children reduces duration and severity.

D. Prevention and Control

1. During an Outbreak:
  1. Verification of diagnosis - Stool culture for V. cholerae O1/O139.
  2. Notification - Mandatory reporting locally, nationally, and to WHO within 24 hours under International Health Regulations (IHR). An area is declared cholera-free when twice the incubation period (10 days) has elapsed since the last case.
  3. Early case finding - Active community surveillance for mild/moderate cases.
  4. Establish treatment centers - Accessible cholera treatment centers (CTCs); mildly dehydrated patients treated at home with ORS.
  5. Rehydration therapy - As above (cornerstone).
  6. Epidemiological investigation - Identify source, mode of spread, and implement targeted control.
  7. Water control - Emergency chlorination, boiling, distribution of safe water in narrow-mouthed covered containers.
  8. Excreta disposal - Emergency sanitary latrine provision; disinfection of feces with lime or bleach.
  9. Food hygiene - Avoid raw/undercooked food; proper food storage; boil or cook thoroughly.
  10. Contact tracing and chemoprophylaxis - Household contacts may receive a short course of antibiotics.
  11. Health education - Community messaging on ORS use, hand washing, water safety.
  12. Disinfection of the environment - Surfaces, clothing, bedding in cholera households.
2. Long-term Prevention:
  • Safe piped water supply and sewage treatment infrastructure.
  • Open defecation-free communities (ODF campaigns).
  • Hand hygiene promotion (soap at point of use).
  • Food safety laws and enforcement.
  • Oral cholera vaccines in high-risk/endemic areas.
  • Intersectoral coordination (Health + Water + Local Government).

Question 4a (Short Note, 2054)

"Killed oral cholera vaccine"

Killed Oral Cholera Vaccine (OCV)

Background: Recognizing that safe water and sanitation may take decades to achieve in low-resource settings, WHO recommends oral killed cholera vaccines as part of a comprehensive cholera control strategy.
Currently WHO-prequalified killed oral cholera vaccines:
VaccineCompositionManufacturer
Shanchol (BivWC)Whole-cell killed V. cholerae O1 (El Tor + Classical biotypes, Inaba + Ogawa serotypes) + O139; NO cholera toxin B subunitShantha Biotechnics, India (manufacture being terminated)
Euvichol / Euvichol-PlusSame as Shanchol; currently accounts for the vast majority of global OCV supplyEubiologics, South Korea
Dukoral (WC-rBS)Whole-cell killed V. cholerae O1 + 1 mg recombinant cholera toxin B subunit (rBS) per doseValneva, Sweden
Administration:
  • 2-dose regimen (doses separated by 14 days) for Dukoral and Euvichol.
  • 3-dose regimen for children 2-5 years (Dukoral).
  • Oral route (dissolved in buffer solution for Dukoral; direct oral for Shanchol/Euvichol).
Efficacy:
  • Provides 60-85% protection in the first few months after vaccination.
  • Shanchol/Euvichol: ~60% protection over 5 years in all age groups; ~40% in children ≤5 years.
  • Even a single dose of BivWC provides 40-63% adjusted protection for 6 months in outbreak settings (though not effective in children <5 years with single dose).
  • Significant herd immunity when coverage exceeds 50%.
  • Safely administered in HIV-positive populations.
Boosters:
  • Dukoral: every 2 years for ≥6-year-olds; every 6 months for children 2-5 years.
  • Shanchol/Euvichol: no formal booster schedule, but re-vaccination recommended in continued high-risk.
WHO Strategy: In 2017, WHO launched the Global Task Force on Cholera Control (GTFCC) with a target to reduce cholera deaths by 90% by 2030. This includes maintaining an international stockpile of OCV for rapid outbreak response. Nepal has used stockpile vaccines during post-earthquake outbreak response.
Mechanism of Protection: Killed whole-cell vaccines stimulate both serum vibriocidal antibodies (IgM/IgG) and intestinal secretory IgA responses. The rCTB component in Dukoral additionally stimulates anti-toxin immunity and may also provide some cross-protection against ETEC (enterotoxigenic E. coli) diarrhea due to structural similarity between CT-B and LT-B subunits.
Limitations:
  • Does not replace the need for WASH interventions.
  • Shorter duration of protection compared to natural infection.
  • Less effective in young children (under 5).
  • Requires cold chain and two doses (logistical challenges in remote Nepal).

Sources: Park's Textbook of Preventive and Social Medicine (PSM); Harrison's Principles of Internal Medicine 22E; Goldman-Cecil Medicine

Hi

Hi! How can I help you today?
This is a shared conversation. Sign in to Orris to start your own chat.